Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Bossi

Showing results (141-150 of 151) with videos related to

Pageof 16
Sort By:
European Journal of Cancer (Oxford, England : 1990)|November 9, 2016
A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impactL D Locati, F Perrone, B Cortelazzi, et al.
Oral Oncology|April 8, 2026
A prospective study with Comprehensive Geriatric Assessment (CGA) before curative treatment in older patients with locally advanced head and neck squamous cell carcinoma (LA-HNSCC)M Cossu Rocca, A Esposito, S Vecchio, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 10, 2019
The pathogenesis of mucositis: updated perspectives and emerging targetsJ Bowen, N Al-Dasooqi, P Bossi, et al.
ESMO Open|December 30, 2025
A multiomic framework for predicting laryngo-esophageal dysfunction following induction chemotherapy in hypopharyngeal-laryngeal carcinomaD Mattavelli, M Compagnoni, S Calza, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 19, 2018
Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN)J-P Machiels, P Bossi, J Menis, et al.
ESMO Open|February 22, 2025
Sinonasal malignancy: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-upC Resteghini, B Baujat, P Bossi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 4, 2024
Operational classification of cutaneous squamous cell carcinomas based on unsupervised clustering of real cases by expertsC Gaudy-Marqueste, J J Grob, C Garbe, et al.
Oral Oncology|March 23, 2024
How reliable is assessment of true vocal cord-arytenoid unit mobility in patients affected by laryngeal cancer? a multi-institutional study on 366 patients from the ARYFIX collaborative groupM Ferrari, F Mularoni, S Taboni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2026
ESMO Adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumoursK S Saini, M Koopman, D Martins-Branco, et al.
Oral Oncology|June 9, 2024
Corrigendum to "How reliable is assessment of true vocal cord-arytenoid unit mobility in patients affected by laryngeal cancer? a multi-institutional study on 366 patients from the ARYFIX collaborative group" [Oral Oncol. 152C (2024) 106744]M Ferrari, F Mularoni, S Taboni, et al.
Pageof 16

Showing results (141-150 of 151) with videos related to

Sort By:
Pageof 16
European Journal of Cancer (Oxford, England : 1990)|November 9, 2016
A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impactL D Locati, F Perrone, B Cortelazzi, et al.
Oral Oncology|April 8, 2026
A prospective study with Comprehensive Geriatric Assessment (CGA) before curative treatment in older patients with locally advanced head and neck squamous cell carcinoma (LA-HNSCC)M Cossu Rocca, A Esposito, S Vecchio, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 10, 2019
The pathogenesis of mucositis: updated perspectives and emerging targetsJ Bowen, N Al-Dasooqi, P Bossi, et al.
ESMO Open|December 30, 2025
A multiomic framework for predicting laryngo-esophageal dysfunction following induction chemotherapy in hypopharyngeal-laryngeal carcinomaD Mattavelli, M Compagnoni, S Calza, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 19, 2018
Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN)J-P Machiels, P Bossi, J Menis, et al.
ESMO Open|February 22, 2025
Sinonasal malignancy: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-upC Resteghini, B Baujat, P Bossi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 4, 2024
Operational classification of cutaneous squamous cell carcinomas based on unsupervised clustering of real cases by expertsC Gaudy-Marqueste, J J Grob, C Garbe, et al.
Oral Oncology|March 23, 2024
How reliable is assessment of true vocal cord-arytenoid unit mobility in patients affected by laryngeal cancer? a multi-institutional study on 366 patients from the ARYFIX collaborative groupM Ferrari, F Mularoni, S Taboni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2026
ESMO Adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumoursK S Saini, M Koopman, D Martins-Branco, et al.
Oral Oncology|June 9, 2024
Corrigendum to "How reliable is assessment of true vocal cord-arytenoid unit mobility in patients affected by laryngeal cancer? a multi-institutional study on 366 patients from the ARYFIX collaborative group" [Oral Oncol. 152C (2024) 106744]M Ferrari, F Mularoni, S Taboni, et al.
Pageof 16